Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Sampliner

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Gut|December 6, 2006
Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagusKaterina Dvorak, Claire M Payne, Melissa Chavarria, et al.
Gastroenterology|May 30, 2013
Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohortSrinivas Gaddam, Mandeep Singh, Gokulakrishnan Balasubramanian, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2013
Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasiaRajeswari Anaparthy, Srinivas Gaddam, Vijay Kanakadandi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2010
Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinomaSachin Wani, Gary Falk, Matthew Hall, et al.
Endoscopy|April 25, 2015
Clinical outcomes in patients with a diagnosis of "indefinite for dysplasia" in Barrett's esophagus: a multicenter cohort studyPreetika Sinh, Rajeswari Anaparthy, Patrick E Young, et al.
Gastroenterology|July 5, 2011
Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagusSachin Wani, Gary W Falk, Jane Post, et al.
Gastroenterology|August 19, 2007
Five-year colon surveillance after screening colonoscopyDavid A Lieberman, David G Weiss, William V Harford, et al.
Cancer Research|May 14, 2009
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagusZhe Jin, Yulan Cheng, Wen Gu, et al.
The American Journal of Gastroenterology|June 2, 2017
Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) ConsortiumSachin Wani, V Raman Muthusamy, Nicholas J Shaheen, et al.
Gastrointestinal Endoscopy|June 4, 2017
Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) ConsortiumSachin Wani, V Raman Muthusamy, Nicholas J Shaheen, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Gut|December 6, 2006
Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagusKaterina Dvorak, Claire M Payne, Melissa Chavarria, et al.
Gastroenterology|May 30, 2013
Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohortSrinivas Gaddam, Mandeep Singh, Gokulakrishnan Balasubramanian, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2013
Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasiaRajeswari Anaparthy, Srinivas Gaddam, Vijay Kanakadandi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2010
Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinomaSachin Wani, Gary Falk, Matthew Hall, et al.
Endoscopy|April 25, 2015
Clinical outcomes in patients with a diagnosis of "indefinite for dysplasia" in Barrett's esophagus: a multicenter cohort studyPreetika Sinh, Rajeswari Anaparthy, Patrick E Young, et al.
Gastroenterology|July 5, 2011
Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagusSachin Wani, Gary W Falk, Jane Post, et al.
Gastroenterology|August 19, 2007
Five-year colon surveillance after screening colonoscopyDavid A Lieberman, David G Weiss, William V Harford, et al.
Cancer Research|May 14, 2009
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagusZhe Jin, Yulan Cheng, Wen Gu, et al.
The American Journal of Gastroenterology|June 2, 2017
Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) ConsortiumSachin Wani, V Raman Muthusamy, Nicholas J Shaheen, et al.
Gastrointestinal Endoscopy|June 4, 2017
Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) ConsortiumSachin Wani, V Raman Muthusamy, Nicholas J Shaheen, et al.
Pageof 6